UNSPSC 51162036: Potassium iodide/theophylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162036 Potassium iodide/theophylline is a Commodity code that in recent state and local procurement activity has been tagged to emergency-response pharmaceuticals, pharmacy benefit management services, and cooperative purchasing of generic multi-source drugs and over-the-counter products—a scope considerably broader than the code's nominal chemical designation. State and local issuing bodies soliciting under this code include county health departments and government family health centers, state health and human services agencies, and state cooperative purchasing alliances. Work currently being procured ranges from emergency naloxone procurement and drug deactivation systems to on-site pharmacy services for employee health plans, direct-to-manufacturer prescription programs, and bulk pharmaceutical supply agreements. The issuing bodies span counties (Seminole County, Florida; Hall County, Georgia), state agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, which serves Minnesota, Oregon, and participating jurisdictions).

Recent representative opportunities include Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; Hall County, Georgia's RFQ/P for on-site pharmacy services at its Family Health Center Clinic with evaluation of 80 technical questions and cost proposals, due June 4, 2026; the Texas Health and Human Services Commission's April 2026 RFI on direct-to-manufacturer prescription programs to gather vendor capabilities before issuing a formal RFP; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with proposals due March 26, 2026 and awards effective July 1, 2026. Geographic activity concentrates in Florida, Georgia, Texas, and Minnesota, with the cooperative vehicle extending across multiple states including Oregon. The code shows significant recent activity across emergency-response pharmaceuticals, employer health plan pharmacy services, and large-scale pharmaceutical supply contracting.